2020
Clinical Pathway for Management of Suspected or Positive Novel Coronavirus-19 Patients With ST-Segment Elevation Myocardial Infarction.
Ranard LS, Ahmad Y, Masoumi A, Chuich T, Romney MS, Gavin N, Sayan OR, Kirtane AJ, Rabbani LE. Clinical Pathway for Management of Suspected or Positive Novel Coronavirus-19 Patients With ST-Segment Elevation Myocardial Infarction. Critical Pathways In Cardiology A Journal Of Evidence-Based Medicine 2020, 19: 49-54. PMID: 32356955, DOI: 10.1097/hpc.0000000000000223.Peer-Reviewed Original ResearchConceptsST-elevation myocardial infarctionMyocardial infarctionNewYork-Presbyterian/Columbia University Irving Medical CenterST-segment elevation myocardial infarctionManagement of STEMIColumbia University Irving Medical CenterStandard cardiac careElevation myocardial infarctionCOVID-19 patientsCoronavirus-19 patientsCoronavirus-19 diseaseOverwhelming healthcare systemsCOVID-19 diseaseFibrinolytic therapyCardiac careMultidisciplinary panelClinical pathwayMedical CenterSTEMI mimicsHealthcare systemInfarctionPatientsDiseaseGlobal pandemicMyopericarditis
2016
Resolving the paradox of randomised controlled trials and observational studies comparing multi-vessel angioplasty and culprit only angioplasty at the time of STEMI
Ahmad Y, Cook C, Shun-Shin M, Balu A, Keene D, Nijjer S, Petraco R, Baker CS, Malik IS, Bellamy MF, Sethi A, Mikhail GW, Al-Bustami M, Khan M, Kaprielian R, Foale RA, Mayet J, Davies JE, Francis DP, Sen S. Resolving the paradox of randomised controlled trials and observational studies comparing multi-vessel angioplasty and culprit only angioplasty at the time of STEMI. International Journal Of Cardiology 2016, 222: 1-8. PMID: 27448698, DOI: 10.1016/j.ijcard.2016.06.106.Peer-Reviewed Original ResearchConceptsHigh-risk patientsLarge observational studiesObservational studyResidual diseaseMulti-vessel coronary artery diseaseHigh mortalityPrimary percutaneous coronary interventionST-elevation myocardial infarctionPercutaneous coronary interventionCoronary artery diseaseReal-world patientsOptimal treatment strategyAllocation biasCoronary interventionCulprit arteryRisk patientsArtery diseaseMyocardial infarctionSmall RCTsWorld patientsTreatment strategiesPatientsEquivalent mortalitySTEMIMortality97 Multi-vessel Angioplasty at the Time of STEMI has Equivalent Mortality to a Culprit Only Strategy: Resolving The Paradox of Randomised Controlled Trials and Observational Studies in Multivessel Disease and STEMI
Ahmad Y, Cook C, Petraco R, Nijjer S, Al-Lamee R, Shun-Shin M, Keene D, Balu A, Malik I, Baker C, Mikhail G, Sethi A, Foale R, Davies J, Mayet J, Francis D, Sen S. 97 Multi-vessel Angioplasty at the Time of STEMI has Equivalent Mortality to a Culprit Only Strategy: Resolving The Paradox of Randomised Controlled Trials and Observational Studies in Multivessel Disease and STEMI. Heart 2016, 102: a68. DOI: 10.1136/heartjnl-2016-309890.97.Peer-Reviewed Original ResearchHigh-risk patientsLarge observational studiesObservational studyResidual diseaseEquivalent mortalityPrimary percutaneous coronary interventionST-elevation myocardial infarctionMulti-vessel diseasePercutaneous coronary interventionRandomised Controlled TrialsAllocation biasMultivessel diseaseCoronary interventionRisk patientsControlled TrialsMyocardial infarctionSmall RCTsPatientsHigh mortalitySTEMIMortalityDiseaseConflicting resultsRCTsPPCI